We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$2.5B
AUM Growth
+$112M
Cap. Flow
+$22.9M
Cap. Flow %
0.92%
Top 10 Hldgs %
54.31%
Holding
65
New
15
Increased
17
Reduced
8
Closed
25

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$149M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$95.6M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$92.9M
4
UNH icon
UnitedHealth
UNH
+$86.5M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$81.1M

Top Sells

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$145M
2
LH icon
Labcorp
LH
+$92M
3
CI icon
Cigna
CI
+$88.6M
4
EHC icon
Encompass Health
EHC
+$77.2M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$74.8M

Sector Composition

Rank Sector Weight
1 Healthcare 98.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZBH icon
1
Zimmer Biomet
ZBH
$18.4B
$178M 7.12%
1,345,355
+1,141,054
+559% +$149M
UNH icon
2
UnitedHealth
UNH
$383B
$159M 6.38%
511,370
+281,720
+123% +$86.5M
MDT icon
3
Medtronic
MDT
$110B
$146M 5.83%
1,402,160
+486,720
+53% +$48.9M
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$139M 5.57%
1,790,310
+1,389,270
+346% +$95.6M
MDGL icon
5
Madrigal Pharmaceuticals
MDGL
$11.4B
$134M 5.37%
1,129,948
-67,936
-6% -$7.38M
IQV icon
6
IQVIA
IQV
$39.1B
$133M 5.3%
840,740
+295,950
+54% +$46.4M
AUPH icon
7
Aurinia Pharmaceuticals
AUPH
$1.93B
$131M 5.23%
8,873,953
-627,445
-7% -$9.09M
ABBV icon
8
AbbVie
ABBV
$455B
$116M 4.62%
1,318,900
+1,330
+0.1% +$125K
HCA icon
9
HCA Healthcare
HCA
$85.7B
$115M 4.62%
926,310
+125,020
+16% +$15.5M
REGN icon
10
Regeneron Pharmaceuticals
REGN
$77.4B
$107M 4.26%
190,310
+133,760
+237% +$81.1M
NVRO
11
DELISTED
NEVRO CORP.
NVRO
$102M 4.08%
730,977
-323,126
-31% -$43.2M
VRTX icon
12
Vertex Pharmaceuticals
VRTX
$122B
$98.6M 3.95%
362,390
+336,770
+1,314% +$92.9M
HUM icon
13
Humana
HUM
$44B
$94.8M 3.79%
228,930
+159,380
+229% +$64.1M
GH icon
14
Guardant Health
GH
$20.2B
$89.2M 3.57%
797,730
+78,890
+11% +$7.22M
NBIX icon
15
Neurocrine Biosciences
NBIX
$18.7B
$89.1M 3.57%
927,070
+571,300
+161% +$66.1M
COO icon
16
Cooper Companies
COO
$14.2B
$81.4M 3.26%
+966,160
New +$74.1M
ARCT icon
17
Arcturus Therapeutics
ARCT
$168M
$68.4M 2.74%
1,594,452
+1,500,252
+1,593% +$74.5M
RPRX icon
18
Royalty Pharma
RPRX
$26.2B
$63M 2.52%
1,496,410
+580,060
+63% +$24.9M
AMGN icon
19
Amgen
AMGN
$209B
$59.4M 2.38%
233,740
-25,460
-10% -$6.31M
TFX icon
20
Teleflex
TFX
$5.86B
$56.2M 2.25%
+165,160
New +$61.2M
CRL icon
21
Charles River Laboratories
CRL
$11.3B
$54.9M 2.2%
242,230
+141,500
+140% +$29.4M
MD icon
22
Pediatrix Medical
MD
$2.17B
$52.7M 2.11%
3,234,280
-153,685
-5% -$2.86M
ARNA
23
DELISTED
Arena Pharmaceuticals Inc
ARNA
$43.2M 1.73%
578,030
+97,570
+20% +$6.51M
DHR icon
24
Danaher
DHR
$138B
$31.1M 1.25%
163,109
-261,769
-62% -$46.6M
THC icon
25
Tenet Healthcare
THC
$21.8B
$27.3M 1.09%
1,114,980
+986,741
+769% +$25.2M
1
2 3

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q3 2020 Portfolio in Review

As of Q3 2020, HealthCor Management held 65 positions worth $2.5B, up 4.7% from $2.39B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

HealthCor Management's Q3 2020 filing shows 15 new, 17 increased, 8 reduced and 25 closed positions. Its largest new stake was Cooper Companies: 966,160 shares worth $81.4M. The largest sale was Becton Dickinson, an estimated $145M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier.

  • HealthCor Management's largest Q3 2020 buy was Cooper Companies: 966,160 shares worth $81.4M.
  • HealthCor Management added most to Zimmer Biomet in Q3 2020, an estimated $149M increase.
  • HealthCor Management's biggest Q3 2020 reduction was Bristol-Myers Squibb, cutting an estimated $56.4M.
  • HealthCor Management fully exited Becton Dickinson in Q3 2020, selling an estimated $145M.
  • HealthCor Management's ten largest holdings make up 54% of its $2.5B portfolio in Q3 2020.
  • HealthCor Management opened 15 new positions and closed 25 in Q3 2020.
  • HealthCor Management's portfolio value rose 4.7% quarter-over-quarter to $2.5B.

Based on HealthCor Management's 13F filing for Q3 2020, filed 16 Nov 2020.